Grünenthal uses its own and third-party cookies to improve the browsing experience, offer personalized content and improve its services. We use analytics scripts which set tracking cookies. More details and information can be found in our Data Privacy Statement – please refer to this to adjust your settings for website analytics tracking (e.g. enable/disable). By closing this window you agree to our standard Terms of Use.

I'm ok with this

Innovation | PainSolve 
;

Innovation &
Pipeline

Finding solutions that improve patients’ lives

We aim to deliver major therapeutic advances by treating patients with a high burden of disease, offering clear benefits for patients and sound health economics for society. Our exciting R&D pipeline includes several new drug candidates and technologies to improve patients’ lives.

At Grünenthal, there is close collaboration between all stakeholders involved in research, and each is equally important. Our networked approach to R&D means that we can interlink and supplement our own expertise with external knowledge, leading to improved outcomes.

Fueling our pipeline with innovation

Latest Updates

Omics Approach to Identify Pain Pathways

Read our article about the steps we have taken to generate an integrated disease pathway map for pain which contains the major pathophysiological components.

... Discover more

Psychosocial Factors in Profiling IBS Patients

Read our article on how relevant the neuro-visceral axis is for the expression of symptoms from which visceral pain conditions, like IBS, can originate.

... Discover more

Patient Focus Groups as a Strategy to Engage with Patients

Read our article which introduces patient focus group methodology, its role in pain research, and provides advice on planning and running a patient focus group.

... Discover more

Patient Focus Groups as a Strategy to Engage with Patients

Read our article which introduces patient focus group methodology, its role in pain research, and provides advice on planning and running a patient focus group.

... Discover more
Like
 
Share

Share this with:

These are external links and will open in a new window